ロード中...
Successful use of tPA for thrombolysis in COVID related ARDS: a case series
We describe successful usage of low dose Tissue plasminogen activator (tPA) (30–50 mg) in three COVID19 critically ill patients, who were in worsening respiratory failure in-spite of being on therapeutic anticoagulation. All patients had respiratory rate > 40; FiO(2) > 0.7(on NIV); PiO(2)/FiO(...
保存先:
| 出版年: | J Thromb Thrombolysis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330540/ https://ncbi.nlm.nih.gov/pubmed/32617806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02208-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|